Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases.
Fuzhong F. Zheng(Memorial Sloan Kettering Cancer Center), Neal Rosen(Memorial Sloan Kettering Cancer Center), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Scott D. Kuduk(Kettering University), Gabriela Chiosis(Memorial Sloan Kettering Cancer Center), Samuel J. Danishefsky(Kettering University), Pamela N. Münster(University of California, San Francisco)
PubMed
April 15, 2000
Cited by 81
Related Papers
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
|Cancer Research|2006|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
|Nature|2011|1.4k
BRAF mutation predicts sensitivity to MEK inhibition
|Nature|2005|1.3k